MedEx Research Staffing: Your source for technical and scientific employment.
CenterWatch: Subscribe to Research Practitioner
CenterWatch PI Guide

Webinars

August | September |

June 6 - August 22, 2014 (Fridays)

Barnett International

10-Week Clinical Research Associate (CRA) On-Boarding Program

8:30 AM - 11:30 AM Eastern

The online 10-Week Clinical Research Associate (CRA) On-Boarding Program is appropriate for individuals with less than two years of experience as a CRA. The course provides practical, hands-on training as it relates to the CRA job function, and covers core sponsor and research site activities that promote the successful monitoring of studies for drug, biologic, and device trials. The course follows an ICH/ISO global GCP framework, and covers how to identify specific country requirements, making it appropriate for both U.S. and global audiences. Good Clinical Practice (GCP) skills are reinforced through a combination of activities, including lecture, case studies, and scenario review, as well as application-based homework assignments.

August

August 14 - October 16, 2014

Barnett International

30-Hour Clinical Project Management Fundamentals Certificate Program

5:00 PM - 8:00 PM Eastern

In today’s outsourcing environment, the need for strong project management skills is greater than ever. This comprehensive hands-on 30-hour course is designed to provide the tools necessary to become a strong project manager in clinical research. Whether you are looking to become a clinical research project manager, you are already in an entry-level project manager role or you have become an “accidental” project manager by assignment, this program will provide you with project management skills development as well as the necessary tools and processes required to successfully manage projects in clinical research settings. The course includes an emphasis on the need to anticipate, understand, and implement detailed project management activities in a proactive manner. Discussions, exercises, and tools are practically oriented with an emphasis given to practical application of key concepts and principles.

August 15 - October 24, 2014

Barnett International

10-Week Clinical Research Coordinator (CRC) On-Boarding Program

12:00 PM - 3:00 PM Eastern

The Clinical Research Coordinator (CRC) has a vital role in the conduct of a clinical trial and is a key liaison between the investigator, subject, IRB, and sponsor. The online 10-Week Clinical Research Coordinator (CRC) On-Boarding Program will provide a comprehensive introduction to clinical research and the job functions of the CRC for both drug/biologic and device trials. This program will provide core skills and encourage critical thinking to those individuals looking to support, facilitate, and coordinate the daily activities of clinical trials. Case studies and industry best practices will be presented to underscore how the learning objectives apply directly to the responsibilities of the CRC.

September

September 3, 2014

Barnett International

Improving Readability of SOPs and Other Procedural Documents

12:15 PM - 2:15 PM Eastern

No one really likes reading SOPs. Whether this is a true “necessary evil” or not, this, in itself, makes it important that the associated pain is minimized. More often than not, the contents of the SOPs are simply “tossed” into a document with little ado. Such an approach perpetuates a vicious circle: First, the user, not being able to fully comprehend what they are reading, simply stops reading; then, authors, knowing the document won’t be read, don’t put effort into writing it. The by-product of these events is that compliance suffers. Fortunately, there is a way to break out of this circle: (1) develop documents that SOP users can understand; and (2) present the contents in an easy to view way. Regardless of the content, the better its presentation, the more likely the document is to be read and used.

September 4, 2014

Barnett International

Trial Master File (TMF) for Sponsors: Set Up and Maintenance

8:30 AM - 10:30 AM Eastern

The Trial Master File (TMF) is a collection of the essential documents for a sponsor to record how they have fulfilled their obligations as sponsor for a clinical trial project. This web seminar reviews the sponsor TMF required and additional content for a clinical trial. The activities of set-up, maintenance, and quality control and assurance will be discussed along with common deficiencies and challenges. This course will also include handouts and discussion of the TMF Reference Model.

September 4, 2014

Barnett International

Introduction to Data Management

9:30 AM - 11:30 AM Eastern

This web seminar provides an excellent introduction to clinical research data management, focusing on processes and their rationale, making it ideal for the new data manager and other individuals who wish to learn basic clinical data management functions.

September 4, 2014

Barnett International

Use of Notes to File in Clinical Trial Essential Documentation

12:00 PM - 1:30 PM Eastern

Notes to File (NTF), also known as Memo to File, are commonly used as essential documentation in sponsor and site files. Many times the content of the NTF does not serve the purpose for use or serves no purpose at all. This web seminar will discuss the appropriate and inappropriate uses of NTF, the questions to ask to determine if NTF would be beneficial, and the components of a quality NTF, if being used.

September 5, 2014 - November 7, 2014

Barnett International

10-Week Clinical Research Associate (CRA) On-Boarding Program

8:30 AM - 11:30 AM Eastern

The online 10-Week Clinical Research Associate (CRA) On-Boarding Program is appropriate for individuals with less than two years of experience as a CRA. The course provides practical, hands-on training as it relates to the CRA job function, and covers core sponsor and research site activities that promote the successful monitoring of studies for drug, biologic, and device trials. The course follows an ICH/ISO global GCP framework, and covers how to identify specific country requirements, making it appropriate for both U.S. and global audiences. Good Clinical Practice (GCP) skills are reinforced through a combination of activities, including lecture, case studies, and scenario review, as well as application-based homework assignments.

September 8, 2014

Barnett International

How to Write Effective Monitoring Reports and Communications Workshop

9:00 AM - 4:00 PM Eastern

Clinical Monitors (CRAs) must document many details of the happenings at investigational sites, including Confirmation Letters to sites, Monitoring Visit Reports, Follow-Up Letters to sites, Telephone Contact Reports, Email/Faxes to sites, and Queries and Notes to File (NTF). All of these become essential documents as they demonstrate the compliance of the monitor and, thus, the sponsor in the conduct of the clinical trial. These are all eligible for inspection by the regulatory authorities at any time both during and after the study is completed and submitted for product approval. This is the same regulation for drugs, biologics, and devices. Effective writing skills are, therefore, extremely important so that we show the diligence and detail involved in effective monitoring. Increasingly, we notice that the Confirmation Letters, Monitoring Visit Reports, and Follow-Up Letters have discrepancies. This may be simple date inconsistencies, or critical data credibility issues. It is important that the monitor be aware of the importance of these issues in the review of study documentation. This module will provide some practical solutions to addressing document deficiencies as well as provide a practical understanding of how these documents provide evidence for the regulated activities of the investigator and the sponsor.

September 8, 2014

Barnett International

Cases in Advanced GCP: A Problem-Solving Practicum

9:00 AM - 12:00 PM Eastern

This application-based web seminar covers advanced concepts and challenges encountered in the application of Good Clinical Practice (GCP). During this highly interactive course, participants will review and discuss cases that include GCP challenges in topic areas such as IRB/IEC approval, informed consent, drug accountability and reconciliation, SUSAR submissions, communications with ethics committees and health authorities, as well as the management of investigational product. Cases are based on actual industry examples, and participants are expected to solve cases by applying Root Cause Analysis (RCA) and Corrective and Preventive Action (CAPA) principles, which are briefly reviewed.

September 9, 2014

Barnett International

Quality by Design: A Lean Six Sigma Approach to Risk-Based Monitoring

9:30 AM - 11:00 AM Eastern

Monitoring consumes 30-60% of an operational budget for clinical trials or clinical programs. To sustain growth and reinvest in innovation, sponsors must find viable alternatives to reduce the resource burn, as well as create efficient and effective solutions to increase regulatory compliance, data integrity, and patient safety. By utilizing the combined toolboxes of Lean Six Sigma (LSS) + Quality by Design (QbD), sponsors can continue to invest in innovative products while producing customer-centric/efficient operational processes that are highly adaptable, constantly reproducible, and consume fewer resources. LSS + QbD provides CRAs and other risk-based monitoring staff with an arsenal of analytical tools to conduct fewer on site monitoring visits yet monitor the site more effectively and in real-time.

September 9, 2014

Barnett International

Data Management: Key Regulations Impacting the Role of the Clinical Data Manager

9:30 AM - 11:00 AM Eastern

In conducting clinical research, there are some specific regulations that directly impact the discipline of Clinical Data Management (CDM). 21 CFR Part 11 includes mandatory regulations that govern clinical trials data. It requires a system in which electronic records and signatures are trustworthy, reliable, and secure; electronic signatures that are equivalent to paper records and handwritten signatures executed on paper; a system that discerns invalid or altered records; and signatures that are linked to an electronic record.

September 10, 2014

Barnett International

Establishing a Risk Management Framework for Clinical Trial Conduct and Oversight

1:00 PM - 2:30 PM Eastern

As many organizations move to, or contemplate, a risk-based approach to trial conduct and quality management, the published regulatory agency documents and industry think tank publications fall short in providing sponsors, CROs, and clinical vendors the framework—a comprehensive, systematic, structured approach to implementing risk management. This web seminar will provide an overview of a risk management reference model for use that has been adopted by other industries and is referenced in the FDA Guidance of 2013, "Oversight of Clinical Investigations — A Risk- Based Approach to Monitoring."

September 11, 2014

Barnett International

SOP Writing: How to Create, Implement, and Maintain User-Friendly SOPs Workshop

9:30 AM - 4:00 PM Eastern

In the world of clinical research, it would be difficult to find someone who hasn’t heard of Standard Operating Procedures (SOPs). Yet there remains great mystery in how to create an SOP.

September 12, 2014

Barnett International

Writing Quality SOPs: Guidelines, Tools, and Templates for Easy SOP Creation

12:00 PM - 2:30 PM Eastern

Standard Operating Procedures (SOPs) are detailed written instructions that allow one to execute a process uniformly. Many SOPs are not well defined or well written, and actually fall short of providing the details needed for one to complete the process. In fact, many who are assigned the task of creating SOPs lack the basic understanding of what constitutes a well written SOP. Often SOPs appear to be no more than a brief Note to File, leaving gaps in the proper execution of the task delegated. Poorly written SOPs also leave organizations vulnerable in the event of an audit.

September 15, 2014

Barnett International

Risk-Based Monitoring for Sites: Prepare Your Site for Success

9:00 AM - 10:30 AM Eastern

Over the past few years, a new term has emerged in the clinical research industry: Risk-Based Monitoring (RBM). What is it? Why is it becoming more widely used? How does it impact Investigators and sites? This web seminar will provide an overview of the principles of RBM and describe how this new approach to monitoring differs from “traditional” monitoring. Learners will gain an understanding of both regulatory and industry factors influencing the adoption of Risk-Based Monitoring. This web seminar will help participants anticipate the possible changes brought on by RBM, and provide strategies to prepare their sites for success.

September 15, 2014

Barnett International

Investigator Initiated Trials: Roles and Responsibilities

9:00 AM - 11:30 AM Eastern

Investigator Initiated Trials (IITs), also referred to as Sponsor-Investigator (SI) Trials are increasing in popularity. A Sponsor-Investigator is anyone who functions as the Clinical Investigator (CI) of a given study and who also holds the investigational marketing application, i.e., the IND or IDE. How does the CI ensure compliance to both the investigator and sponsor responsibilities? This web seminar will present the responsibilities, discuss risk, and provide suggestions for compliance.

September 15, 2014

Barnett International

Risk-Proof Your Sites: Monitoring Strategies for Managing Risks

1:00 PM - 3:00 PM Eastern

The concepts and processes of risk management are well known and often used in clinical research project management. Yet, few clinical research monitors realize the value of applying these activities to site management. This web seminar starts with an overview of risk assessment and management. The learner is then guided through the application of these techniques through all phases of study conduct: Site selection and initiation, routine monitoring, and site close-out. The course focuses on identification of site strengths and weaknesses and implementing strategies to address weaknesses before they lead to deviations or noncompliance.

September 16, 2014

Barnett International

Quality Risk Management in Clinical Trials and Pharmacovigilance

9:00 AM - 10:30 AM Eastern

The ICH Q9 Quality Risk Management (QRM) guideline has become an accepted standard, facilitating the development and implementation of a systematic risk-based approach to quality management of clinical trials and pharmacovigilance. Industry and regulatory bodies, including the EMA and FDA, have recognized the need and benefits of implementing a risk-based approach to quality management.

September 16, 2014

Barnett International

30-Hour Clinical Project Management Fundamentals Certificate Program

9:00 AM - 12:00 PM Eastern

In today’s outsourcing environment, the need for strong project management skills is greater than ever. This comprehensive hands-on 30-hour course is designed to provide the tools necessary to become a strong project manager in clinical research. Whether you are looking to become a clinical research project manager, you are already in an entry-level project manager role or you have become an “accidental” project manager by assignment, this program will provide you with project management skills development as well as the necessary tools and processes required to successfully manage projects in clinical research settings. The course includes an emphasis on the need to anticipate, understand, and implement detailed project management activities in a proactive manner. Discussions, exercises, and tools are practically oriented with an emphasis given to practical application of key concepts and principles.

September 16, 2014

Barnett International

Developing Clinical Study Budgets for Sponsors

12:30 PM - 2:30 PM Eastern

In an environment where studies are becoming more challenging to execute and taking more resources and time than anticipated, it is key to develop a solid and flexible budget to allow for study execution challenges. In developing a budget it is critical to address all standard line items such as reimbursement for procedures, but how can the oversight and follow-up time be accurately calculated? How does Fair Market Value (FMV) criteria factor into budget development? What questions should be asked to determine additional, unwritten, study expectations? What are some key elements leading to delayed budget negotiation and approval? This web seminar will address the fundamentals of budget development and considerations for ensuring that budgets are developed fairly to ensure that sites are appropriately reimbursed for study expectations.

September 17, 2014

Barnett International

Electronic Medical Records: Approaches for Ensuring Source Document and 21 CFR Part 11 Required Components

12:00 PM - 2:30 PM Eastern

Current societal events have influenced the increased use of an electronic medical record (EMR), one being the promotion of a national electronic medical record. More and more research sites are using an EMR for all or part of their case histories for research subjects. The industry has defined the characteristics that source documents in any form must include, and 21 CFR Part 11 includes standards for electronic source data. Challenges in monitoring the original source document have been growing and unaddressed in many situations. The FDA’s final guidance document for 21 CFR Part 11 supports certain characteristics that EMRs should include, but many site electronic records do not meet the requirements. This web seminar will discuss assessment of EMRs, ideal monitoring vs. contingency planning, and risk management.

September 18, 2014

Barnett International

Risk-Based Site Monitoring

9:00 AM - 10:30 AM Eastern

In the current GCP regulatory climate, risk-based decision making should be supported within the clinical Quality System. A management approach used in many industries where performance is critical under tight timelines for regulated activities, risk-based decision making makes sense for such activities as sponsor monitoring in clinical research. Applying a risk-based approach to the monitoring and site management should be based on a given project’s risk profile. A risk- based approach can address current monitoring practices that are costly and ineffective, and help projects meet financial and compliance goals. This web seminar will present the concepts and case scenarios of risk-based monitoring (RBM).

September 18, 2014

Barnett International

State Laws Governing Clinical Trial Regulatory Compliance

9:30 AM - 11:00 AM Eastern

Although many clinical trial sponsors and investigators focus primarily on FDA regulations related to the conduct and design of clinical trials, their failure to comply with state laws and regulations may expose sponsors, investigators, IRBs, institutions, or individuals may call into question the potential integrity of clinical data. Today’s U.S.-based clinical trials must meet not just federal requirements, but an increasingly complex array of state-specific requirements, many of which are critical and foundational to clinical studies. The capacity to consent to experimental therapy has its foundational basis and is governed by state law.

September 18, 2014

Barnett International

Approaches to Address Challenges in Vendor Management

12:00 PM - 2:30 PM Eastern

Outsourcing in clinical development continues to grow and so do the challenges of ensuring quality outcomes. Managing a vendor vs. micro-managing a vendor will be discussed with some practices to improve the relationship. Recommendations for sponsor oversight practices are discussed with a review of helpful tools.

September 22, 2014

Barnett International

Trial Master Files: Why They are Important and How to Organize Them Workshop

9:00 AM - 4:00 PM Eastern

The Trial Master File is a collection of the essential documents for a sponsor to record how they have fulfilled their obligations for a clinical trial. The Code of Federal Regulations states in 21 CFR 312.50 that, “Sponsors are responsible for… ensuring that the investigation(s) is conducted in accordance with the general investigational plan and protocols contained in the IND.” The European Directive 2005/28/EC states that, “the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.” ICH GCP, Section 8.1 defines these essential documents as those that individually and collectively permit evaluation of the conduct of a trial and the quality of the data produced.

September 22, 2014

Barnett International

Source Documentation: What is Adequate & Accurate

9:30 AM - 11:30 AM Eastern

Lack of adequate and/or accurate source documentation has been noted as a common deficiency in inspection findings of Clinical Investigators. There is significant variability between stakeholder requirements regarding source documentation per study, including sponsor to sponsor, sponsor to site, etc. The creation and use of source document worksheets and the use of the Case Report Form (CRF) as the original source have raised a lot of industry debate. These issues and more regarding adequate and accurate source documentation to meet the requirements of regulatory agencies essential documentation standards will be presented and discussed.

September 22, 2014

Barnett International

Monitoring Plan Development

1:00 PM - 3:00 PM Eastern

Although monitoring plans are not defined or specifically required by FDA regulations or the ICH Guideline for Good Clinical Practice, both organizations endorse the use of this tool in a Quality Systems management approach to clinical research. The traditional approach to monitoring plan development has relied upon reinforcing SOP-mandated monitoring activities with little focus on project and/or protocolspecific monitoring needs. This web seminar provides participants with concepts and templates to set up a monitoring plan that supports unique project risks and links to valuable data regarding investigative site and Clinical Research Associate (CRA) performance. Suggestions for development of monitoring plans for a risk-based approach to monitoring are also provided in this session.

September 23, 2014

Barnett International

The FDA Medical Device Pre-Submission Package and FDA Meetings

12:30 PM - 3:30 PM Eastern

The FDA Medical Device Pre-Submission program is intended for companies to use in order to obtain FDA feedback on future applications prior to their submission. The applications include Investigational Device Exemptions (IDEs), Premarket Approvals (PMAs), Humanitarian Device Exemptions (HDEs), and Premarket Notifications (510(k)s). This program allows the FDA to provide advice to applicants who are developing clinical and nonclinical testing protocols which are submitted with the company’s application. The program also allows the FDA to work with applicants from medical device concept to market. This web seminar will provide learners with information about how to prepare for and conduct various FDA meetings, specifically addressing the types of applications that companies file with the FDA.

September 23, 2014

Barnett International

CRA Current Practice Update: Impact of the FDA BIMO Program

1:00 PM - 3:00 PM Eastern

The FDA announced in 2006 an initiative to modernize the regulation of clinical trials, including the BIMO inspections program. This includes conducting inspections and other assessments earlier in the development of a potential product to build quality into the clinical trial upfront rather than assessing it at trial completion. From this initiative, the FDA has generated new guidance and regulation that directly affect the performance of the sponsor monitor. The initiative is a dynamic process and this web seminar tracks the updates that directly affect monitoring. Examples of how to implement the agency requirements and recommendations into current practices and specific projects are also covered.

September 24, 2014

Barnett International

Protocol Deviations: Documenting, Managing, and Reporting

1:00 PM - 3:00 PM Eastern

According to both U.S. regulations and the ICH Good Clinical Practice: Consolidated Guideline, Clinical Investigators are required to conduct a clinical trial in compliance with the investigational plan/protocol. Protocol deviations should not be implemented without sponsor agreement and the prior approval/favorable opinion from the IRB/IEC, except when necessary to eliminate an immediate safety issue for research subjects. However, unapproved protocol deviations occur in every study and at every site.

September 24, 2014

Barnett International

Strategies for Protocol Operationalization and Adherence

1:00 PM - 2:30 PM Eastern

Protocols are rising in complexity, length, and numbers of procedures. Protocol training is trending toward webinars vs. live meetings where questions are more limited and less likely to be asked. With more to do and less time and instruction, taking on new and challenging protocols can be daunting. This web seminar will focus on some introductory steps to taking a protocol apart and making it operational and executable without deviations at a site. Topics to be addressed include how to get the most out of the initial protocol review, understanding and putting into practice the patient flow, and how to ensure protocol adherence in a busy, ever-changing site environment.

September 24, 2014

Barnett International

Principal Investigator Oversight and the Appropriate Delegation of Tasks

3:00 PM - 4:30 PM Eastern

Principal Investigators (PIs) are required to provide adequate oversight of all clinical research activities at the site, whether the activity is conducted by the PI, by study team members, or by applicable third parties. Adequate oversight encompasses many activities and obligations, such as ensuring regulatory compliance, staff training, and subject medical care. In this web seminar, we will discuss the regulatory requirements and guidance regarding adequate investigator oversight and appropriate delegation of study tasks, review documentation requirements, and determine strategies for appropriate delegation of tasks.